The store will not work correctly when cookies are disabled.
2-Amino-4-(4-(2-hydroxyethyl)piperazin-1-yl)-7H-pyrrolo[2,3-d]-pyrimidine-5-carbonitrile
ID: ALA4102550
PubChem CID: 137657569
Max Phase: Preclinical
Molecular Formula: C13H17N7O
Molecular Weight: 287.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1c[nH]c2nc(N)nc(N3CCN(CCO)CC3)c12
Standard InChI: InChI=1S/C13H17N7O/c14-7-9-8-16-11-10(9)12(18-13(15)17-11)20-3-1-19(2-4-20)5-6-21/h8,21H,1-6H2,(H3,15,16,17,18)
Standard InChI Key: UVKWLMKUGNQKSD-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
12.7847 -20.9745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7836 -21.7941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4916 -22.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4898 -20.5657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1985 -20.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2033 -21.7896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9833 -22.0380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4607 -21.3729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9755 -20.7135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0756 -22.2021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2224 -19.9371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4704 -19.1585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4874 -19.7485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1919 -19.3407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1914 -18.5271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4843 -18.1168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7760 -18.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7748 -19.3461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4849 -17.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1930 -16.8916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1936 -16.0744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
11 12 3 0
9 11 1 0
4 13 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
16 19 1 0
19 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 287.33 | Molecular Weight (Monoisotopic): 287.1495 | AlogP: -0.47 | #Rotatable Bonds: 3 |
Polar Surface Area: 118.09 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.04 | CX Basic pKa: 7.36 | CX LogP: 0.08 | CX LogD: -0.28 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.70 | Np Likeness Score: -1.29 |
References
1. Anthony NG, Baiget J, Berretta G, Boyd M, Breen D, Edwards J, Gamble C, Gray AI, Harvey AL, Hatziieremia S, Ho KH, Huggan JK, Lang S, Llona-Minguez S, Luo JL, McIntosh K, Paul A, Plevin RJ, Robertson MN, Scott R, Suckling CJ, Sutcliffe OB, Young LC, Mackay SP.. (2017) Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers., 60 (16): [PMID:28737909] [10.1021/acs.jmedchem.7b00484] |